Heart Failure Is Rising Fast in the U.S. and Striking Younger Adults

Heart failure is heading in the wrong direction in America, and a sweeping 2026 report from the Heart Failure Society of America makes the scale of the problem undeniable. Published in the Journal of Cardiac Failure, the HF STATS 2026 report compiles the latest epidemiological data and warns that without meaningful intervention, the burden will grow dramatically in the decades ahead.

Currently, an estimated 7.7 million U.S. adults — about 3% of the adult population — live with heart failure. Projections show that number climbing to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. Roughly one in four Americans is now expected to develop heart failure at some point in their lifetime. The primary drivers are an aging population alongside rising rates of obesity, hypertension, and cardiometabolic disease.

Perhaps most alarming is the mortality trend. Age-adjusted heart failure death rates increased by approximately 37% between 2010 and 2023, reversing over a decade of prior improvements. Even younger adults are affected: among those aged 25–44, unadjured mortality rates more than doubled between 2001 and 2020, and nearly doubled in the 45–64 age group — signaling that this is no longer a disease confined to the elderly.

A critical gap exists between available treatments and their actual use. The four pillars of guideline-directed medical therapy — beta-blockers, renin-angiotensin system inhibitors, mineralocorticoid receptor antagonists, and SGLT2 inhibitors — are used together by only 18% of eligible patients with reduced ejection fraction heart failure. These are proven, relatively inexpensive therapies, yet they remain profoundly underutilized in real-world practice.

Experts call for electronic health record decision-support tools, multidisciplinary care programs, and simplified medication regimens to close this gap. For health-conscious individuals, the report underscores the urgency of controlling cardiometabolic risk factors — blood pressure, weight, blood sugar — as primary prevention against a condition that is becoming increasingly common and increasingly deadly.